• Profile
Close

Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial

The Lancet: Gastroenterology & Hepatology Oct 14, 2019

Everitt HA, Landau S, O'Reilly G, et al. - In adults with refractory irritable bowel syndrome (IBS), researchers conducted this follow-up study to assess longer-term (24 month) clinical outcomes of telephone cognitive behavioural therapy (CBT) and web CBT vs treatment as usual (TAU). Five hundred fifty-eight adults with refractory IBS were randomly allocated to obtain either therapist-delivered telephone CBT (telephone-CBT group), web-based CBT with minimal therapist support (web-CBT group), or treatment as usual (TAU group) and were followed up for 12 months in the ACTIB three-group, randomised, controlled trial. Sustained improvements in IBS were found in both CBT groups relative to TAU at 24-month follow-up, although some earlier gains compared with 12-month results were decreased. IBS-specific CBT has the ability to provide long-term improvement in IBS that can be accomplished within the usual clinical setting. The long-term patient benefit could be gained by increasing access to CBT for IBS. There have been no treatment-related adverse events.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay